CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 84 filers reported holding CUREVAC N V in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,966 | -37.2% | 600 | 0.0% | 0.00% | – |
| Q2 2023 | $6,317 | +51.0% | 600 | 0.0% | 0.00% | – |
| Q1 2023 | $4,183 | +15.1% | 600 | 0.0% | 0.00% | – |
| Q4 2022 | $3,635 | -59.6% | 600 | -43.4% | 0.00% | – |
| Q3 2022 | $9,000 | -35.7% | 1,060 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -33.3% | 1,060 | 0.0% | 0.00% | – |
| Q1 2022 | $21,000 | -41.7% | 1,060 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $36,000 | -37.9% | 1,060 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $58,000 | -27.5% | 1,060 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $80,000 | +90.5% | 1,060 | +130.4% | 0.00% | +100.0% |
| Q1 2021 | $42,000 | – | 460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $11,332,823 | 10.01% |
| RA Capital Management | 12,245,955 | $85,354,306 | 1.93% |
| Avidity Partners Management LP | 3,550,000 | $24,743,500 | 0.82% |
| Camber Capital Management LP | 1,250,000 | $8,713 | 0.27% |
| Ghisallo Capital Management LLC | 100,000 | $697,000 | 0.17% |
| FOX RUN MANAGEMENT, L.L.C. | 31,278 | $218,008 | 0.07% |
| Alyeska Investment Group, L.P. | 1,060,382 | $7,390,863 | 0.06% |
| Green Alpha Advisors, LLC | 12,351 | $86,086 | 0.06% |
| Virtus ETF Advisers LLC | 14,114 | $98,375 | 0.05% |
| Quantamental Technologies LLC | 11,146 | $77,688 | 0.04% |